Neovascular Glaucoma with Diabetic Retinopathy: Trabeculectomy and Nd:YAG Cyclophotocoagulation.
- Author:
Chang Ryong KIM
1
;
Yang Rae MA
;
Kun Jin YANG
Author Information
1. Department of Ophthalmology, Chonnam University Medical School, Gwangju, Korea.
- Publication Type:Original Article
- Keywords:
Cyclophotocoagulation;
Neovascular glaucoma;
Trabeculectomy
- MeSH:
Diabetic Retinopathy*;
Glaucoma, Neovascular*;
Humans;
Hyphema;
Medical Records;
Postoperative Complications;
Retrospective Studies;
Trabeculectomy*
- From:Journal of the Korean Ophthalmological Society
2001;42(11):1581-1587
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: We carried out to determine the effectiveness of trabeculectomy and neodymium:YAG (Nd: YAG) cyclophotocoagulation in eyes with neovascular glaucoma from diabetic retinopathy. METHODS: We retrospectively reviewed medical records of patients who had undergone trabeculectomy or Nd:YAG cyclophotocoagulation from May 1992 to August 1997. RESULTS: The average drop in IOP was 24.6 mmHg in the trabeculectomy group and 17.3 mmHg in the transscleral cyclophotocoagulation group. Success rate was 69.2% in the trabeculectomy group and 21.4% in the transscleral cyclophotocoagulation group. Most common postoperative complication was hyphema (38.4%) in the trabeculectomy group and phthisis bulbi (21.4%) in the transscleral cyclophotocoagulation group. CONCLUSIONS: Trabeculectomy had higher success rate and less serious complications than transscleral cyclophotocoagulation. Transcleral cyclophotocoagulation may be considered as a treatment of neovascular glaucoma in the patients who have severe pain or poor general condition.
